Biodexa Pharmaceticals Net Asset Quality Index
Biodexa Pharmaceticals net asset quality index. Biodexa Pharmaceticals (BDRX) has a Net Asset Quality Index of 62.7% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $18.15 Million minus total liabilities of $6.76 Million yields net assets of $11.38 Million. A higher index indicates a stronger, lower-leverage balance sheet. See BDRX total equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Biodexa Pharmaceticals (2012–2025)
Net asset quality index of Biodexa Pharmaceticals from 2012 to 2025. This chart shows how Biodexa Pharmaceticals's Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of December 2025, the index stands at 62.7%, representing net assets of $11.38 Million against total assets of $18.15 Million USD. Check how strategically is Biodexa Pharmaceticals's equity deployed to assess the company's strategic physical and investment asset allocation.
Biodexa Pharmaceticals Net Asset Quality Index by Year (2012–2025)
Biodexa Pharmaceticals net asset quality index by year from 2012 to 2025. The table below presents the year-by-year Net Asset Quality Index for Biodexa Pharmaceticals from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see how much is Biodexa Pharmaceticals worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 62.7% | $11.38 Million | $18.15 Million | $6.76 Million | ▲ +6.4 pp |
| 2024 | 56.3% | $8.32 Million | $14.78 Million | $6.46 Million | ▲ +11.9 pp |
| 2023 | 44.4% | $4.68 Million | $10.54 Million | $5.86 Million | ▼ -12.9 pp |
| 2022 | 57.2% | $3.16 Million | $5.53 Million | $2.36 Million | ▼ -23.7 pp |
| 2021 | 80.9% | $10.45 Million | $12.91 Million | $2.46 Million | ▲ +12.5 pp |
| 2020 | 68.4% | $6.72 Million | $9.82 Million | $3.10 Million | ▲ +5.1 pp |
| 2019 | 63.3% | $19.56 Million | $30.89 Million | $11.34 Million | ▼ -19.5 pp |
| 2018 | 82.8% | $16.92 Million | $20.44 Million | $3.52 Million | ▲ +12.3 pp |
| 2017 | 70.4% | $34.68 Million | $49.22 Million | $14.55 Million | ▼ -10.2 pp |
| 2016 | 80.7% | $45.72 Million | $56.69 Million | $10.96 Million | ▲ +7.4 pp |
| 2015 | 73.2% | $46.89 Million | $64.04 Million | $17.15 Million | ▼ -16.8 pp |
| 2014 | 90.0% | $41.99 Million | $46.66 Million | $4.67 Million | ▲ +75.3 pp |
| 2013 | 14.7% | $760.00K | $5.17 Million | $4.41 Million | ▲ +243.9 pp |
| 2012 | -229.2% | $-8.28 Million | $3.61 Million | $11.89 Million | — |